# Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement

> **NCT00508326** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 27 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00508326
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00508326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00508326, "Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00508326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*